While the prevalence of migraine amongst Americans has remained fairly constant over the last fifteen years, our knowledge of migraine and the treatment options have grown significantly. What have we learned most recently about migraine and about vascular risks associated with migraine? Dr. Stephen Silberstein, professor of neurology and director of the Jefferson Headache Center at Thomas Jefferson University, joins host Dr. Anthony Alessi to discuss the latest research on treating migraine and the vascular risks associated with migraine.
ReachMD
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Vascular Risks of Migraines
Share this program on:
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
Recommended
Details
Presenters
Comments
Recommended
Overview
While the prevalence of migraine amongst Americans has remained fairly constant over the last fifteen years, our knowledge of migraine and the treatment options have grown significantly. What have we learned most recently about migraine and about vascular risks associated with migraine? Dr. Stephen Silberstein, professor of neurology and director of the Jefferson Headache Center at Thomas Jefferson University, joins host Dr. Anthony Alessi to discuss the latest research on treating migraine and the vascular risks associated with migraine.
Presenters
Facebook Comments